2025
SJR Q2
JCR Q2 · 3,7
142 matched articles
SCIE
Journal detail
Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0022357320427158
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,765
- Quartile Q2
- H-Index 148
- Cites/doc 4,12
- Docs (3y) 406
- Cites (3y) 1.676
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,7
- 5Y JIF 3,7
- JCI 0,77
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmaceutical Science Q2
- Pharmacology Q2
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,765 | 3,7 | 3,7 | 0,77 | Q2 | 148 |
| 2024 | Q2 | Q2 | 0,717 | 3,2 | 3,9 | 0,77 | Q2 | 142 |
| 2023 | Q2 | Q2 | 0,648 | 2,8 | 3,8 | 0,77 | Q2 | 142 |
| 2022 | Q1 | Q2 | 0,686 | 3,3 | 3,7 | 0,86 | Q2 | 142 |
| 2021 | Q2 | Q2 | 0,646 | 4,8 | 4 | 0,88 | Q2 | 142 |
| 2020 | Q1 | Q2 | 0,745 | 3,8 | 3,5 | 0,88 | Q2 | 142 |
| 2019 | Q2 | Q3 | 0,58 | 2,6 | 2,7 | 0,81 | Q2 | 142 |
| 2018 | — | Q3 | — | 2,4 | 2,7 | 0,78 | Q2 | — |
| 2017 | Q1 | Q3 | 0,657 | 2,3 | 2,6 | 0,82 | Q2 | 142 |
| 2016 | Q1 | Q3 | 0,74 | 2,4 | 2,5 | — | — | 142 |
| 2015 | Q1 | Q2 | 0,696 | 2,4 | 2,4 | — | — | 142 |
| 2014 | Q1 | Q3 | 0,711 | 2,3 | 2,4 | — | — | 142 |
| 2013 | Q1 | Q3 | 0,681 | 2,2 | 2,3 | — | — | 142 |
| 2012 | Q1 | Q3 | 0,671 | 2 | 2,1 | — | — | 142 |
| 2011 | Q1 | Q2 | 0,694 | 2,2 | 2,1 | — | — | 142 |
| 2010 | Q1 | Q3 | 0,655 | 1,9 | 2 | — | — | 142 |
| 2009 | — | Q3 | — | 1,7 | 1,9 | — | — | — |
| 2008 | — | Q3 | — | 1,8 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 1,7 | 1,7 | — | — | — |
| 2006 | — | Q3 | — | 1,5 | — | — | — | — |
| 2005 | — | Q3 | — | 1,4 | — | — | — | — |
| 2004 | — | Q3 | — | 1,3 | — | — | — | — |
| 2003 | — | Q3 | — | 1,5 | — | — | — | — |
| 2002 | — | Q3 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q3 | — | 1,2 | — | — | — | — |
| 1999 | — | Q2 | — | 1,2 | — | — | — | — |
| 1998 | — | Q3 | — | 0,8 | — | — | — | — |
| 1997 | — | Q3 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 120/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 126/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 158/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 138/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 83/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 122/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 149/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 150/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 146/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 127/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 133/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 148/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 128/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 144/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 154/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 133/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 123/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 118/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 104/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 110/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 109/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 96/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 112/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 109/157 |